Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

117.46 -0.67 (-0.57%)
Streaming Delayed Price Updated: 11:21 AM EST, Nov 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
40 41 Next >
CBOE Volatility Index Drops To Lowest Level Since November 2021; S&P 500 Ends Almost Flat
The S&P 500 closed almost flat on Wednesday following the release of corporate earnings. 
Via Benzinga
Tesla, Rivian, IBM, Zions, Lam Research: Why These Five Stocks Are Drawing Investors' Attention Today
Via Benzinga
Why Medtronic Stock Soared More Than 4% Higher Today
The veteran device maker did well on a very good day for stocks in its industry. 
Via The Motley Fool
Nasdaq Edges Higher; Abbott Laboratories Reports Upbeat Results
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Wednesday. The Dow traded down 0.23% to 33,899.20 while the NASDAQ rose 0.16% to 12,172.92. The S&P 500,... 
Via Benzinga
Abbott's Q1 Earnings Beat Estimates, Margins Down
Abbott Laboratories reported first-quarter 2023 adjusted earnings of $1.03 per share. 
Via Talk Markets
Check Out What Whales Are Doing With ABT
Via Benzinga
Abbott Laboratories (NYSE: ABT) is a Leading Gainer in Wednesday Morning Trading
Via Investor Brand Network
Why Abbott Laboratories Shares Are Trading Higher Today?
Via Benzinga
Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering. 
Via Benzinga
Diversified Abbott Laboratories Could Reverse And Move Higher
Abbott Laboratories reported a solid quarter driven by gains in the core business that are accelerating as COVID sales decline. 
Via MarketBeat
Exposures COVID-19
Abbott Labs Shakes Off Covid Test Decline To Top First-Quarter Estimates
Covid tests are still expected to bring in $1.5 billion in sales this year. 
Via Investor's Business Daily
New York Rep. Daniel Goldman Sold Over $50K Worth of Abbott Laboratories Stock: Here's What You Should Know
Via Benzinga
A Preview Of Abbott Laboratories's Earnings
Via Benzinga
Meta Prepares For Further Job Cuts, Google To Allow Developers To Use Alternative Payment Options, Intel Ditches Production Of Bitcoin Mining Chip: Today's Top Stories
Bloomberg 
Via Benzinga
2 Stocks That Could Help Make You a Millionaire by Retirement
These companies are accustomed to delivering excellent returns. 
Via The Motley Fool
Nasdaq, S&P Futures Falter As Mixed Earnings Weigh Down On Sentiment
Earnings continue to be front and center in the market, with futures trading signaling a negative start on Wednesday. More bellwether names are due to turn in their quarterly scorecard, potentially... 
Via Benzinga
10 Analysts Have This to Say About Abbott Laboratories
Via Benzinga
Morgan Stanley, Tesla And 3 Stocks To Watch Heading Into Wednesday
With US futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Investor Optimism Declines Following Earnings Reports
The CNN Money Fear and Greed index showed some decline in overall sentiment among U.S. investors on Tuesday. U.S stocks closed mostly flat on Tuesday as investors digested the recent batch of earnings... 
Via Benzinga
Major Earnings Misses And Beats: Your Guide To This Week's Big Earnings In Play
We saw other large financial companies report their earnings along with stocks across other sectors miss or exceed expectations though the broader market was completely unchanged by the close. 
Via Talk Markets
Abbott Laboratories, National Retail Properties, UnitedHealth Group And A Big Bank Reporting Upbeat Earnings: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Brenda Vingiello of Sand Hill Global Advisors named Abbott Laboratories (NYSE: ABT) 
Via Benzinga
Profit from the Artificial Intelligence Boom with These 7 AI ETFs
The artificial intelligence revolution is already here, creating a massive $1.81 trillion opportunity for AI ETFs. 
Via InvestorPlace
What's In Store For Abbott Laboratories In Q1 Earnings?
Abbott Laboratories is slated to report first-quarter 2023 results on Apr. 19 before the market opens. 
Via Talk Markets
3 No-Brainer Medical Device Stocks to Buy Right Now
These companies have consistently delivered revenue and EPS gains. 
Via The Motley Fool
3 Discounted Dividend Stocks With Combined 150+ Years Of Dividend Growth
All three of these dividend stocks have paid a growing dividend for more than 25 years each 
Via The Motley Fool
Better Dividend Stock: AbbVie vs. Johnson & Johnson
Both companies have a lot to offer income-seekers. 
Via The Motley Fool
3 Dividend-Growth Stocks to Buy in April That Can Crush Inflation
No need to worry about keeping up with inflation with these rapidly growing payouts. 
Via The Motley Fool
3 Healthcare Stocks to Watch As the Industry Evolves
Healthcare stocks are often considered a safe investment due to the consistent demand for medical products and services. 
Via InvestorPlace
2 Dividend Stocks Down 11% to 22% to Buy and Hold Forever
Investors should buy the dips on these healthcare giants. 
Via The Motley Fool
Can Healthcare Stocks Survive Macro Headwinds?
Healthcare stocks are supposed to be defensive plays in a choppy market. However, over the past 18 months, the XLV is flat and down 6% over one year. 
Via Talk Markets
< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
40 41 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.